Enzon Pharmaceuticals ENZN Stock
0.13 USD
{{ price }}
-9.551716%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
OTC Markets OTCPK
Market Cap
9.73M USD
LOW - HIGH [24H]
0.11
-
0.14 USD
VOLUME [24H]
6.69K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Enzon Pharmaceuticals Price Chart
Enzon Pharmaceuticals ENZN Financial and Trading Overview
| Enzon Pharmaceuticals stock price | 0.13 USD |
| Previous Close | 0.14 USD |
| Open | 0.14 USD |
| Bid | 0.38 USD x 3000 |
| Ask | 1.41 USD x 200 |
| Day's Range | 0.14 - 0.14 USD |
| 52 Week Range | 0.12 - 0.45 USD |
| Volume | 26.05K USD |
| Avg. Volume | 15.48K USD |
| Market Cap | 10.46M USD |
| Beta (5Y Monthly) | 0.198591 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | September 30, 2019 |
| 1y Target Est | 14 USD |
ENZN Valuation Measures
| Enterprise Value | 7.4M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 402.4715 |
| Price/Book (mrq) | 3.4390244 |
| Enterprise Value/Revenue | 284.678 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Enzon Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.198591 |
| 52-Week Change | -48.14% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.45 USD |
| 52 Week Low | 0.12 USD |
| 50-Day Moving Average | 0.18 USD |
| 200-Day Moving Average | 0.25 USD |
ENZN Share Statistics
| Avg. Volume (3 month) | 15.48K USD |
| Avg. Daily Volume (10-Days) | 17.26K USD |
| Shares Outstanding | 74.21M |
| Float | 30.21M |
| Short Ratio | 1.71 |
| % Held by Insiders | 10.70% |
| % Held by Institutions | 48.58% |
| Shares Short | 259.38K |
| Short % of Float | 0.67% |
| Short % of Shares Outstanding | 0.58% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 1161.53% |
| Operating Margin (ttm) | -3923.076% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -1.35% |
| Return on Equity (ttm) | 0.64% |
Income Statement
| Revenue (ttm) | 26K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 26K USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -973000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 45.88M USD |
| Total Cash Per Share (mrq) | 0.62 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 113.375 |
| Book Value Per Share (mrq) | 0.041 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -277000 USD |
| Levered Free Cash Flow (ttm) | -978500 USD |
Profile of Enzon Pharmaceuticals
| Country | United States |
| State | NJ |
| City | Cranford |
| Address | 20 Commerce Drive |
| ZIP | 07016 |
| Phone | 732 980 4500 |
| Website | https://www.enzon.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Q&A For Enzon Pharmaceuticals Stock
What is a current ENZN stock price?
Enzon Pharmaceuticals ENZN stock price today per share is 0.13 USD.
How to purchase Enzon Pharmaceuticals stock?
You can buy ENZN shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enzon Pharmaceuticals?
The stock symbol or ticker of Enzon Pharmaceuticals is ENZN.
Which industry does the Enzon Pharmaceuticals company belong to?
The Enzon Pharmaceuticals industry is Biotechnology.
How many shares does Enzon Pharmaceuticals have in circulation?
The max supply of Enzon Pharmaceuticals shares is 74.19M.
What is Enzon Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Enzon Pharmaceuticals PE Ratio is now.
What was Enzon Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Enzon Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Enzon Pharmaceuticals company belong to?
The Enzon Pharmaceuticals sector is Healthcare.
Enzon Pharmaceuticals ENZN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite Total Return I XCMP | 20705.72 USD — |
+0.59
|
— — | 20581.18 USD — | 20721.26 USD — | — - | — — |
- {{ link.label }} {{link}}